Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New thermometer aims to take core temperature from the skin

NCT ID NCT07432269

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will check if a new electronic thermometer (XST600) can accurately measure core body temperature when placed on the skin. Researchers will compare its readings to a standard thermometer used in hospitals. About 117 adults who need temperature monitoring will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
XST600 electronic thermometer
What this could lead to
If successful, this could provide a more convenient and accurate way to measure core body temperature through the skin.
What could go wrong
This is a small, early-stage device validation study. The new thermometer may not prove accurate enough to replace current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 117 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Age and Gender: Men and women aged between 19 and 80 years. Clinical Requirement: Patients who need to monitor their body temperature in the operating room or intensive care unit at Severance Hospital. Voluntary Consent: Subjects (or their legal representatives) who have received a detailed explanation of the study and have voluntarily provided written informed consent. Baseline Temperature: Only subjects with a confirmed core temperature of 36.1 or higher (as measured by a Reference Clinical Thermometer) will be included.

Ages

19 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Males and females aged 19 to 80 years. 2. Patients requiring continuous temperature monitoring in the Operating Room or Intensive Care Unit. 3. Subjects (or their legal representatives) who have been fully informed about the study and have voluntarily provided written informed consent. Exclusion Criteria: 1. Skin Conditions: Presence or high risk of skin diseases, wounds, infections, or allergic reactions (e.g., rash) at the application site (forehead). 2. Medication Interference: \* Current use of drugs that may interfere with clinical trial results, such as barbiturates (sedatives/hypnotics), thyroid preparations, or antipsychotic drugs (per ISO 80601-2-56). o Administration of antipyretics within the last 120 minutes or immunization within the last month (per ISO 80601-2-56). 3. Medical History: Any underlying medical condition that may significantly impact the interpretation of the clinical results. 4. Investigator Discretion: Any individual deemed inappropriate for participation by the principal investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for All patients who require monitoring of their temperatures over the age of 19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.